The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients

American Journal of Transplantation

Volumn 12, Issue 7, 2012, Pages 1708-1719

  Sicard, A ^a,b   Phares, T W ^a   Yu, H ^a   Fan, R ^a   Baldwin III, W M ^a   Fairchild, R L ^a   Valujskikh, Anna ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Alloantibody; Bone marrow; Plasma cells; Sensitization; Spleen

Indexed keywords

ALLOANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ALLOSPECIFIC ANTIBODY SECRETING CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HEART TRANSPLANTATION; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIZATION; SPLEEN;

ANIMALS; ANTIBODY FORMATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, ANIMAL; SPLEEN; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84863195824     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04009.x     Document Type: Article

References (45)

1. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807-817. (Pubitemid 41400854)
2. Lefaucheur C, Nochy D, Hill GS, et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 2007; 7: 832-841. (Pubitemid 46481179)
3. Takemoto SK, Zeevi A, Feng S, et al.National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033-1041. (Pubitemid 38868592)
4. Lee PC, Terasaki PI, Takemoto SK, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002; 74 1192-1194. (Pubitemid 35216119)
5. Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574-582. (Pubitemid 32180027)
6. Okada T, Cyster JG. B cell migration and interactions in the early phase of antibody responses. Curr Opin Immunol 2006; 18: 278-285.
7. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011; 29: 621-663.
8. Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity 2007; 27: 190-202. (Pubitemid 47284923)
9. Tarlinton DM, Batista F, Smith KG. The B-cell response to protein antigens in immunity and transplantation. Transplantation 2008; 85: 1698-1704.
10. Oracki SA, Walker JA, Hibbs ML, Corcoran LM, Tarlinton DM. Plasma cell development and survival. Immunol Rev 2010; 237: 140-159.
11. Slifka MK, Ahmed R. Long-lived plasma cells: A mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998; 10: 252-258. (Pubitemid 28286950)
12. Manz RA, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 2005; 23: 367-386. (Pubitemid 40563174)
13. Cyster JG. Homing of antibody secreting cells. Immunol Rev 2003; 194: 48-60. (Pubitemid 36886428)
14. Marques CP, Kapil P, Hinton DR, et al. CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis. J Virol 2011; 85: 6136-6147.
15. Sangster M, Hyland L, Sealy R, Coleclough C. Distinctive kinetics of the antibody-forming cell response to Sendai virus infection of mice in different anatomical compartments. Virology 1995; 207: 287-291.
16. Sangster MY, Topham DJ, D'Costa S, et al. Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol 2000; 164: 1820-1828. (Pubitemid 30108735)
17. Slifka MK, Matloubian M, Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 1995; 69: 1895-1902.
18. Griffin D, Levine B, Tyor W, Ubol S, Despres P. The role of antibody in recovery from alphavirus encephalitis. Immunol Rev 1997; 159: 155-161. (Pubitemid 27499866)
19. Hooper DC, Phares TW, Fabis MJ, Roy A. The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl Trop Dis 2009; 3: e535.
20. Tschen SI, Stohlman SA, Ramakrishna C, Hinton DR, Atkinson RD, Bergmann CC. CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. Eur J Immunol 2006; 36: 603-612.
21. Tyor WR, Griffin DE. Virus specificity and isotype expression of intraparenchymal antibody-secreting cells during Sindbis virus encephalitis in mice. J Neuroimmunol 1993; 48: 37-44.
22. Jones PD, Ada GL. Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection. J Virol 1986; 60: 614-619. (Pubitemid 17174902)
23. Owens GP, Bennett JL, Gilden DH, Burgoon MP. The B cell response in multiple sclerosis. Neurol Res 2006; 28: 236-244. (Pubitemid 43765106)
24. Stegall MD, Dean PG, Gloor J. Mechanisms of alloantibody production in sensitized renal allograft recipients. Am J Transplant 2009; 9: 998-1005.
25. Perry DK, Pollinger HS, Burns JM, et al. Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG. Am J Transplant 2008; 8: 133-143.
26. Amano H, Bickerstaff A, Orosz CG, Novick AC, Toma H, Fairchild RL. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts. J Immunol 2005; 174: 6499-6508. (Pubitemid 40663845)
27. Bickerstaff A, Nozaki T, Wang JJ, et al. Acute humoral rejection of renal allografts in CCR5(-/-) recipients. Am J Transplant 2008; 8: 557-566. (Pubitemid 351287552)
28. Nozaki T, Amano H, Bickerstaff A, et al. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients. J Immunol 2007; 179: 5238-5245.
29. Chen Y, Heeger PS, Valujskikh A. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol 2004; 172: 5456-5466. (Pubitemid 38542046)
30. Valujskikh A, Pantenburg B, Heeger PS. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002; 2: 501-509. (Pubitemid 36306868)
31. Zhang Q, Chen Y, Fairchild RL, Heeger PS, Valujskikh A. Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol 2006; 176: 770-777. (Pubitemid 43099673)
32. Bergmann CC, Lane TE, Stohlman SA. Coronavirus infection of the central nervous system: Host-virus stand-off. Nat Rev Microbiol 2006; 4: 121-132. (Pubitemid 43158155)
33. Zhang QW, Rabant M, Schenk A, Valujskikh A. ICOS-dependent and -independent functions of memory CD4 T cells in allograft rejection. Am J Transplant 2008; 8: 497-506. (Pubitemid 351287530)
34. Amano H, Bickerstaff A, Orosz CG, Novick AC, Toma H, Fairchild RL. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts. J Immunol 2005; 174: 6499-6508. (Pubitemid 40663845)
35. Benner R, van Oudenaren A, Koch G. Induction of antibody formation in mouse bone marrow. Immunological Methods 1981; II: 247-261.
36. Valujskikh A, Heeger P. Enzyme linked immunosorbent spot (ELISPOT) assay for detection of alloreactive cytokine-secreting cells - detailed methods. Graft 2000; 3: 250-258.
37. Alexandre GP, Squifflet JP, De Bruyere M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19: 4538-4542. (Pubitemid 18049656)
38. Lucas JG, Co JP, Nwaogwugwu UT, Dosani I, Sureshkumar KK. Antibody-mediated rejection in kidney transplantation: An update. Expert Opin Pharmacother 2011; 12: 579-592.
39. Sawada T, Fuchinoue S, Kawase T, Kubota K, Teraoka S. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation. Clin Transplant 2004; 18: 254-260. (Pubitemid 38744848)
40. Sawada T, Fuchinoue S, Teraoka S. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation 2002; 74: 1207-1210. (Pubitemid 35402585)
41. Kaplan B, Gangemi A, Thielke J, Oberholzer J, Sankary H, Benedetti E. Successful rescue of refractory, severe antibody mediated rejection with splenectomy. Transplantation 2007; 83: 99-100. (Pubitemid 46104982)
42. Locke JE, Zachary AA, Haas M, et al. The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection. Am J Transplant 2007; 7: 842-846. (Pubitemid 46481192)
43. Baldwin WM, 3rd, Hendry W, Birinyi LK, Jr., Tilney NL. Immune responses to organ allografts. I. Intense B-cell response to heart allografts in lymphoid tissues of unmodified rats. Lab Invest 1979; 40: 695-702. (Pubitemid 9191800)
44. Brown K, Badar A, Sunassee K, et al. SPECT/CT lymphoscintigraphy of heterotopic cardiac grafts reveals novel sites of lymphatic drainage and T cell priming. Am J Transplant 2011; 11: 225-234.
45. Perry DK, Pollinger HS, Burns JM, et al. Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG. Am J Transplant 2008; 8: 133-143.